OR WAIT null SECS
The HCPLive rheumatoid arthritis page is a comprehensive resource for clinical news and insights on arthritis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for RA, and more.
November 06, 2025
Article
The rheumatology month in review emphasizes new data presented at the 2025 ACR Convergence.
October 29, 2025
Video
Graf shared his excitement for a potential new first-in-class therapy for rheumatoid arthritis.
October 26, 2025
Daien shared her excitement for new data supporting fiber supplementation to improve MTX response in rheumatoid arthritis.
October 24, 2025
Mysler emphasized the first definitive evidence informing sequencing after failing a first TNF inhibitor.
October 22, 2025
View slated expert interviews and 6 clinical RA, PsA, and lupus trials to watch at ACR 2025.
October 02, 2025
Q3 2025 saw a number of exciting approvals and data on promising therapies in development.
October 01, 2025
The rheumatology month in review emphasizes new approvals and the latest comparative research.
September 16, 2025
Compared with non-use, taking semaglutide or tirzepatide was associated with improved rheumatoid arthritis disease activity and cardiovascular risk.
September 03, 2025
The rheumatology month in review emphasizes new approvals and best-in-class efficacy data.
August 20, 2025
Rosnilimab shows promising long-term efficacy in treating moderate-to-severe rheumatoid arthritis.